Skip to main content
Toggle navigation
Login
Home
Back
Favorite
1
Like
Facebook
Tweet
Clinical Profile of a PARP inhibitor for the Treatment of mCRPC - Przemyslaw Twardowski, MD
Innovation Theater (Sponsored by AstraZeneca)
Wednesday, September 28, 2022
12:00 PM – 1:00 PM